West Pharmaceutical Services, I (WST)

West Pharmaceutical Services, I attains an AlphaScore of 58/100 in the Healthcare sector. Relevant metrics include a net margin of 16.06% and a revenue growth of 6.25%. A primary strength is its high safety subScore of 89 supported by a low debt-to-equity ratio of 0.06, while a key risk is its elevated forward PE ratio of 36.66. Evidence is limited to the provided snapshot data dated 2026-10-11.

Written 11/10/2026, 00:33:16 UTC · Snapshot 11/10/2026